These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23118926)

  • 1. Everolimus and sirolimus in combination with cyclosporine have different effects on renal metabolism in the rat.
    Bohra R; Schöning W; Klawitter J; Brunner N; Schmitz V; Shokati T; Lawrence R; Arbelaez MF; Schniedewind B; Christians U; Klawitter J
    PLoS One; 2012; 7(10):e48063. PubMed ID: 23118926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urine metabolites reflect time-dependent effects of cyclosporine and sirolimus on rat kidney function.
    Klawitter J; Bendrick-Peart J; Rudolph B; Beckey V; Klawitter J; Haschke M; Rivard C; Chan L; Leibfritz D; Christians U; Schmitz V
    Chem Res Toxicol; 2009 Jan; 22(1):118-28. PubMed ID: 19099400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age and sex differences in the effects of the immunosuppressants cyclosporine, sirolimus and everolimus on rat brain metabolism.
    Gottschalk S; Cummins CL; Leibfritz D; Christians U; Benet LZ; Serkova NJ
    Neurotoxicology; 2011 Jan; 32(1):50-7. PubMed ID: 21075140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of low dose cyclosporine and sirolimus on hepatic drug metabolism in the rat1.
    Bai S; Brunner LJ; Stepkowski SM; Napoli KL; Kahan BD
    Transplantation; 2001 Jun; 71(11):1585-92. PubMed ID: 11435969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic interactions augment toxicities of sirolimus/cyclosporine combinations.
    Podder H; Stepkowski SM; Napoli KL; Clark J; Verani RR; Chou TC; Kahan BD
    J Am Soc Nephrol; 2001 May; 12(5):1059-1071. PubMed ID: 11316866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative tissue distributions of cyclosporine and sirolimus after concomitant peroral administration to the rat: evidence for pharmacokinetic interactions.
    Napoli KL; Wang ME; Stepkowski SM; Kahan BD
    Ther Drug Monit; 1998 Apr; 20(2):123-33. PubMed ID: 9558125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers for toxicodynamic monitoring of immunosuppressants: NMR-based quantitative metabonomics of the blood.
    Serkova NJ; Christians U
    Ther Drug Monit; 2005 Dec; 27(6):733-7. PubMed ID: 16404806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical results of sirolimus treatment in transplant models.
    Stepkowski SM
    Transplant Proc; 2003 May; 35(3 Suppl):219S-226S. PubMed ID: 12742499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of sirolimus with cyclosporine and tacrolimus: analysis of immunosuppression on lymphocyte proliferation and activation in rat whole blood.
    Barten MJ; Streit F; Boeger M; Dhein S; Tarnok A; Shipkova M; Armstrong VW; Mohr FW; Oellerich M; Gummert JF
    Transplantation; 2004 Apr; 77(8):1154-62. PubMed ID: 15114077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressant neurotoxicity in rat brain models: oxidative stress and cellular metabolism.
    Klawitter J; Gottschalk S; Hainz C; Leibfritz D; Christians U; Serkova NJ
    Chem Res Toxicol; 2010 Mar; 23(3):608-19. PubMed ID: 20148532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients.
    Felipe CR; Park SI; Pinheiro-Machado PG; Garcia R; Casarini DE; Moreira S; Tedesco-Silva H; Medina-Pestana JO
    Fundam Clin Pharmacol; 2009 Oct; 23(5):625-31. PubMed ID: 19656203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of glomerular and tubular functions in renal transplant patients receiving cyclosporine A in combination with either sirolimus or everolimus.
    Kamar N; Allard J; Ribes D; Durand D; Ader JL; Rostaing L
    Clin Nephrol; 2005 Feb; 63(2):80-6. PubMed ID: 15730049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of reduced nephron mass on cyclosporine- and/or sirolimus-induced nephrotoxicity.
    Fernandes I; Zhang Y; Qi Y; Wang ME; Podder H; Lisik W; Knight R; Kahan BD; Stepkowski SM
    Transplantation; 2009 Dec; 88(12):1323-31. PubMed ID: 20029328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sirolimus alone or in combination with cyclosporine A on renal ischemia/reperfusion injury.
    Pereira BJ; Castro I; Burdmann EA; Malheiros DM; Yu L
    Braz J Med Biol Res; 2010 Aug; 43(8):737-44. PubMed ID: 20549136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation.
    Schmitz V; Klawitter J; Bendrick-Peart J; Schoening W; Puhl G; Haschke M; Klawitter J; Consoer J; Rivard CJ; Chan L; Tran ZV; Leibfritz D; Christians U
    Nephron Exp Nephrol; 2009; 111(4):e80-91. PubMed ID: 19293597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.
    Shihab FS; Bennett WM; Yi H; Choi SO; Andoh TF
    Kidney Int; 2004 Apr; 65(4):1262-71. PubMed ID: 15086465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interaction between cyclosporine and mTOR inhibitors in experimental model of chronic cyclosporine nephrotoxicity and pancreatic islet dysfunction.
    Piao SG; Bae SK; Lim SW; Song JH; Chung BH; Choi BS; Yang CW
    Transplantation; 2012 Feb; 93(4):383-9. PubMed ID: 22267156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ten-Year Follow-up of Pharmacokinetics-Guided Very Early Cyclosporine Minimization Synchronized With Everolimus Initiation in De Novo Kidney Transplantation.
    Sumethkul V; Tankee P; Worawichawong S; Jirasiritham S
    Transplant Proc; 2017 Oct; 49(8):1743-1746. PubMed ID: 28923619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.